Stock Scorecard



Stock Summary for Quanterix Corp (QTRX) - $5.30 as of 5/30/2025 5:52:01 PM EST

Total Score

11 out of 30

Safety Score

35 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for QTRX

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for QTRX

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for QTRX

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for QTRX

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for QTRX (35 out of 100)

Stock Price Rating (Max of 10) 4
Historical Stock Price Rating (Max of 10) 8
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 8
Analyst Buy Ratings (Max of 5) 2
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 5
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for QTRX

Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal - Akoya Biosciences ( NASDAQ:AKYA ) , Quanterix ( NASDAQ:QTRX ) 5/23/2025 6:21:00 PM
Quanterix Corporation ( QTRX ) Reports Q1 Loss, Tops Revenue Estimates 5/12/2025 9:10:00 PM
Phibro Animal Health ( PAHC ) Q3 Earnings Beat Estimates 5/7/2025 11:40:00 PM
This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Gap ( NYSE:GAP ) , NeoGenomics ( NASDAQ:NEO ) 4/30/2025 11:53:00 AM
Visa To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday - AtriCure ( NASDAQ:ATRC ) , Airbnb ( NASDAQ:ABNB ) 4/30/2025 11:37:00 AM
$HAREHOLDER ALERT: The M&A Class Action Firm Urges Stockholders of AKYA, WTMA, PLYA, QTRX to Act Now 4/28/2025 10:00:00 PM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PPBI, SSBK, AKYA on Behalf of Shareholders - Pacific Premier Bancorp ( NASDAQ:PPBI ) , Akoya Biosciences ( NASDAQ:AKYA ) 4/24/2025 3:47:00 PM
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Pacific Premier Bancorp, Inc. ( Nasdaq - PPBI ) , Southern States Bancshares, Inc. ( Nasdaq - SSBK ) , Akoya Biosciences, Inc. ( Nasdaq - AKYA ) 4/24/2025 3:16:00 PM
$HAREHOLDER ALERT: The M&A Class Action Firm Urges Stockholders of GB, YOTA, PORT, AKYA to Act Now 4/23/2025 10:30:00 PM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AKYA, CKPT, QTRX on Behalf of Shareholders - Akoya Biosciences ( NASDAQ:AKYA ) , Bridge Investment Group ( NYSE:BRDG ) 4/17/2025 11:29:00 PM

Financial Details for QTRX

Company Overview

Ticker QTRX
Company Name Quanterix Corp
Country USA
Description Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advance precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the regions from Asia Pacific. The company is headquartered in Billerica, Massachusetts.
Sector Name LIFE SCIENCES
Industry Name LABORATORY ANALYTICAL INSTRUMENTS
Most Recent Quarter 3/31/2025
Next Earnings Date N/A

Stock Price History

Last Day Price 5.30
Price 4 Years Ago 42.40
Last Day Price Updated 5/30/2025 5:52:01 PM EST
Last Day Volume 397,791
Average Daily Volume 685,029
52-Week High 19.18
52-Week Low 4.05
Last Price to 52 Week Low 30.86%

Valuation Measures

Trailing PE N/A
Industry PE 36.32
Sector PE 40.42
5-Year Average PE -17.24
Free Cash Flow Ratio 2.69
Industry Free Cash Flow Ratio 123.27
Sector Free Cash Flow Ratio 31.66
Current Ratio Most Recent Quarter 8.29
Total Cash Per Share 1.97
Book Value Per Share Most Recent Quarter 8.15
Price to Book Ratio 0.62
Industry Price to Book Ratio 999.10
Sector Price to Book Ratio 29.96
Price to Sales Ratio Twelve Trailing Months 1.51
Industry Price to Sales Ratio Twelve Trailing Months 4.11
Sector Price to Sales Ratio Twelve Trailing Months 40.56
Analyst Buy Ratings 1
Analyst Strong Buy Ratings 1

Share Statistics

Total Shares Outstanding 38,829,400
Market Capitalization 205,795,820
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -19.17%
Reported EPS 12 Trailing Months -1.29
Reported EPS Past Year -0.53
Reported EPS Prior Year -1.03
Net Income Twelve Trailing Months -49,955,000
Net Income Past Year -38,531,000
Net Income Prior Year -32,334,000
Quarterly Revenue Growth YOY -5.40%
5-Year Revenue Growth 19.01%
Operating Margin Twelve Trailing Months -86.90%

Balance Sheet

Total Cash Most Recent Quarter 76,508,000
Total Cash Past Year 56,709,000
Total Cash Prior Year 174,422,000
Net Cash Position Most Recent Quarter 74,565,000
Net Cash Position Past Year 49,021,000
Long Term Debt Past Year 7,688,000
Long Term Debt Prior Year 7,688,000
Total Debt Most Recent Quarter 1,943,000
Equity to Debt Ratio Past Year 0.98
Equity to Debt Ratio Most Recent Quarter 0.99
Total Stockholder Equity Past Year 330,038,000
Total Stockholder Equity Prior Year 346,927,000
Total Stockholder Equity Most Recent Quarter 316,393,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -33,006,000
Free Cash Flow Per Share Twelve Trailing Months -0.85
Free Cash Flow Past Year -38,532,000
Free Cash Flow Prior Year -22,690,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.21
MACD Signal -0.28
20-Day Bollinger Lower Band 3.85
20-Day Bollinger Middle Band 6.78
20-Day Bollinger Upper Band 9.71
Beta 1.12
RSI 51.04
50-Day SMA 10.39
150-Day SMA 15.60
200-Day SMA 20.59

System

Modified 5/29/2025 9:06:47 AM EST